You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康華生物(300841.SZ):完成收購一曜生物10%股權
格隆匯 07-28 20:56

格隆匯 7 月 28日丨康華生物(300841.SZ)公佈,公司於2020年6月28日與上海玉曜生物醫藥科技有限公司(“上海玉曜”)、廣西一曜生物科技有限公司(“一曜生物”)、上海一曜生物技術(集團)有限公司(為一曜生物控股股東)、莊賢韓(為一曜生物實際控制人)簽署了《關於廣西一曜生物科技有限公司之股權轉讓協議》,公司擬以自有資金2800.00萬元收購上海玉曜持有的一曜生物10.00%股權。

公司近日收到一曜生物完成相關股權變更工商登記手續的通知,公司持有一曜生物10.00%的股權。

值得注意的是,一曜生物擬生產的“狂犬病滅活疫苗(PV/BHK-21株)”的生產線處於調試過程中,尚未正式投產。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account